Roche is a Swiss multinational healthcare company headquartered in Basel, operating across pharmaceuticals and diagnostics. It is one of the largest biotechnology companies in the world and a significant investor in externally sourced innovation through research collaborations and licensing agreements.
The pharmaceuticals division develops treatments in oncology, immunology, infectious disease, ophthalmology and neuroscience. Roche has been an active partner for genetic medicine platforms, entering discovery and development collaborations with smaller biotechnology companies working on novel modalities.
In 2024 Roche entered a collaboration with Ascidian Therapeutics covering the discovery and development of RNA exon editing therapeutics targeting neurological diseases.
Facts compiled by Executive Moves from publicly available news and press releases on 22 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you on the Roche team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
